Health Status and Inconveniences of Asthmatic Children During the First Year of the COVID-19 Pandemic

The Coronavirus Disease 2019 (COVID-19) pandemic has been the most significant health concern in recent years, with respiratory symptoms being the most prominent. In children, asthma is the most prevalent chronic disease. Due to the similarities between the symptoms of these two conditions, we sought to assess the general health status of pediatric patients with asthma and their COVID-19-related difficulties during the first year of the pandemic in Iran. We collected data for this study by administering a questionnaire to the parents of 200 children with asthma who were registered in the database of the Asthma Clinic at a tertiary medical center in Tehran, Iran. Forty-five (22.5%) of 200 patients were suspected of having COVID-19, 11 (24.4%) underwent polymerase chain reaction (PCR) testing, and 10 (90.9%) assays were positive. During the first year of the pandemic, 41 patients (20.5%) were referred to a medical center at least once, with 31.7% due to an asthma attack. One hundred eighty-nine patients (94.5%) reported an improved disease status than the previous year, and only 31 patients (15.5%) were using asthma-related medications such as Salbutamol. The estimated mean Asthma Control Test (ACT) scores for two age categories, 4-11 years and 12-18 years, were 25.55±2.27 and 23.28±3.31, respectively, indicating satisfactory disease control. In the majority of our study population, asthma control was acceptable. However, the pandemic caused a significant increase in the anxiety levels of patients and their parents.

Kliničko i patohistološko istraživanje očnih novotvorina u mliječnih goveda

The aim of this study was to show the natural occurrence of ocular neoplasms in dairy cattle kept in 8 dairy farms around Tehran consisting of approximately 5000 dairy cows, over a period of two years. Animal characteristics, type of husbandry and climatic conditions were recorded. Tumours were removed surgically and examined grossly and microscopically. In the present study 32 cases of ocular neoplasms were diagnosed. The affected animals were female (100%), adult and more than 50% of them aged more than five years. In most of the cases (70%) the lesion were located in the nictitating membrane and palpebral conjunctiva. Intraocular invasion was noted in 7 cases (21.87%). Microscopically, in 12 cases out of 32 (37.5%) the tumours were noninvasive squamous cell carcinoma or carcinoma in situ; 18 cases (56.25%) were invasive squamous cell carcinoma; a single case (3.12%) was lymphosarcoma while a further single case (3.12%) was malignant hemangioendothelioma. The grade of malignancy was assessed for each case of neoplasms based on descriptions appearing in the literature. Most of the ocular neoplasms diagnosed were squamous cell carcinoma, mostly located in the nictitating membrane and palpebral conjunctiva.Cilj istraživanja bio je prikazati pojavu očnih novotvorina u tijeku dvije godine u približno pet tisuća mliječnih goveda držanih na osam mliječnih farmi u okolici Teherana. Prikazane su osnovne značajke životinja, tip uzgoja i klimatski uvjeti. Tumori su bili kirurški uklonjeni te pretraženi makroskopski i mikroskopski. Novotvorine oka ustanovljene su u 32 goveda od kojih je više od 50% bilo starijih od pet godina. Promjene su u većini slučajeva (70%) bile smještene na trećoj očnoj vjeđi i spojnicama. Intraokularne promjene zabilježene su u sedam slučajeva (21,87%). Mikroskopski je u 12 (37,5%) slučajeva ustanovljen neinvazivni skvamozni karcinom ili karcinom in situ, u 18 (56,25%) invazivni skvamozni karcinom, u jednom (3,12%) je ustanovljen limfosarkom te također u jednom (3,12%) slučaju bio je ustanovljen maligni hemangioendoteliom. Stupanj malignosti za svaki tumor bio je određen na osnovi literaturnih opisa. Većinom je dijagnosticiran skvamozni karcinom, pretežno smješten na trećoj očnoj vjeđi i spojnicama vjeđa

Activity of opioid ligands in cells expressing cloned mu opioid receptors

BACKGROUND: The aim of the present study was to describe the activity of a set of opioid drugs, including partial agonists, in a cell system expressing only mu opioid receptors. Receptor activation was assessed by measuring the inhibition of forskolin-stimulated cyclic adenosine mono phosphate (cAMP) production. Efficacies and potencies of these ligands were determined relative to the endogenous ligand β-endorphin and the common mu agonist, morphine. RESULTS: Among the ligands studied naltrexone, WIN 44,441 and SKF 10047, were classified as antagonists, while the remaining ligands were agonists. Agonist efficacy was assessed by determining the extent of inhibition of forskolin-stimulated cAMP production. The rank order of efficacy of the agonists was fentanyl = hydromorphone = β-endorphin > etorphine = lofentanil = butorphanol = morphine = nalbuphine = nalorphine > cyclazocine = dezocine = metazocine ≥ xorphanol. The rank order of potency of these ligands was different from that of their efficacies; etorphine > hydromorphone > dezocine > xorphanol = nalorphine = butorphanol = lofentanil > metazocine > nalbuphine > cyclazocine > fentanyl > morphine >>>> β-endorphin. CONCLUSION: These results elucidate the relative activities of a set of opioid ligands at mu opioid receptor and can serve as the initial step in a systematic study leading to understanding of the mode of action of opioid ligands at this receptor. Furthermore, these results can assist in understanding the physiological effect of many opioid ligands acting through mu opioid receptors

Activation profiles of opioid ligands in HEK cells expressing δ opioid receptors

BACKGROUND: The aim of the present study was to characterize the activation profiles of 15 opioid ligands in transfected human embryonic kidney cells expressing only δ opioid receptors. Activation profiles of most of these ligands at δ opioid receptors had not been previously characterized in vitro. Receptor activation was assessed by measuring the inhibition of forskolin-stimulated cAMP production. RESULTS: Naltrexone and nalorphine were classified as antagonists at δ opioid receptor. The other ligands studied were agonists at δ opioid receptors and demonstrated IC(50 )values of 0.1 nM to 2 μM, maximal inhibition of 39–77% and receptor binding affinities of 0.5 to 243 nM. The rank order of efficacy of the ligands tested was metazocine = xorphanol ≥ fentanyl = SKF 10047 = etorphine = hydromorphone = butorphanol = lofentanil > WIN 44,441 = Nalbuphine = cyclazocine ≥ met-enkephalin >> morphine = dezocine. For the first time these data describe and compare the function and relative efficacy of several ligands at δ opioid receptors. CONCLUSIONS: The data produced from this study can lead to elucidation of the complete activation profiles of several opioid ligands, leading to clarification of the mechanisms involved in physiological effects of these ligands at δ opioid receptors. Furthermore, these data can be used as a basis for novel use of existing opioid ligands based on their pharmacology at δ opioid receptors

Single-Layer versus Double-Layer Laparoscopic Intracorporeally Sutured Gastrointestinal Anastomoses in the Canine Model

This study shows that the 1-layer gastrointestinal suture technique is feasible, safe and has fewer complications compared with a 2-layer suture technique

Pharmacological profiles of opioid ligands at Kappa opioid receptors

BACKGROUND: The aim of the present study was to describe the activity of a set of opioid drugs, including partial agonists, in a human embryonic kidney cell system stably expressing only the mouse κ-opioid receptors. Receptor activation was assessed by measuring the inhibition of cyclic adenosine mono phosphate (cAMP) production stimulated by 5 μM forskolin. Intrinsic activities and potencies of these ligands were determined relative to the endogenous ligand dynorphin and the κ agonist with the highest intrinsic activity that was identified in this study, fentanyl. RESULTS: Among the ligands studied naltrexone, WIN 44,441 and dezocine, were classified as antagonists, while the remaining ligands were agonists. Intrinsic activity of agonists was assessed by determining the extent of inhibition of forskolin-stimulated cAMP production. The absolute levels of inhibition of cAMP production by each ligand was used to describe the rank order of intrinsic activity of the agonists; fentanyl = lofentanil ≥ hydromorphone = morphine = nalorphine ≥ etorphine ≥ xorphanol ≥ metazocine ≥ SKF 10047 = cyclazocine ≥ butorphanol > nalbuphine. The rank order of affinity of these ligands was; cyclazocine > naltrexone ≥ SKF 10047 ≥ xorphanol ≥ WIN 44,441 > nalorphine > butorphanol > nalbuphine ≥ lofentanil > dezocine ≥ metazocine ≥ morphine > hydromorphone > fentanyl. CONCLUSION: These results elucidate the relative activities of a set of opioid ligands at κ-opioid receptor and can serve as the initial step in a systematic study leading to understanding of the mode of action of these opioid ligands at this receptor